Journal of the American Society of Nephrology

Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1.  30:2017-2026. 2019

Long-term outcomes of arteriovenous fistulas with unassisted versus assisted maturation: A retrospective national hemodialysis cohort study.  30. 2019

Erratum: Prediction of arteriovenous fistula clinical maturation from postoperative ultrasound measurements: Findings from the hemodialysis fistula maturation study (Journal of the American Society of Nephrology (2018) 29 (2735-2744)DOI:10.1681/ASN.2017111225).  31:665. 2018

A practical guide for treatment of rapidly progressive ADPKD with tolvaptan.  29. 2018

Global cardiovascular and renal outcomes of reduced GFR.  28:2167-2179. 2017

Sickle cell trait and the risk of ESRD in blacks.  28:2180-2187. 2017

Moving beyond minimization trials in kidney transplantation 2015

A national study of outcomes among HIV-infected kidney transplant recipients.  2222-2229. 2015

Current understanding of the role of complement in IgA nephropathy.  1503-1512. 2015

Heme oxygenase-1 regulates myeloid cell trafficking in AKI.  2139-2151. 2015

Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials.  160-172. 2015

Lack of association of the APOL1 G3 haplotype in African Americans with ESRD.  1021-1025. 2015

Reassessing medical risk in living kidney donors.  1017-1019. 2015

Characterization of renal toxicity in mice administered the marine biotoxin domoic acid.  1187. 2014

The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula 2014

Cytomegalovirus and anemia: Not just for transplant anymore.  1613-1615. 2014

ABIN1 dysfunction as a genetic basis for lupus nephritis.  24. 2013

Imatinib: Novel treatment of immune-mediated kidney injury.  24:694-701. 2013

Development of a model of early-onset IgA nephropathy.  23. 2012

Induction of IgA deposits and glomerulonephritis by IgA rheumatoid factor.  23:371-373. 2012

ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells.  22:2187-2192. 2011

Sepsis and acute kidney injury.  22:999-1006. 2011

Medicare reimbursement policies and hemodialysis vascular access outcomes: A need for change.  22:426. 2011

Immunoglobulin light chains activate tubular epithelial cells through redox signaling.  21:1165-1173. 2010

Normal ciliogenesis requires synergy between the cystic kidney disease genes MKS-3 and NPHP-4.  21:782. 2010

Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury.  21:1702-1712. 2010

Cystin localizes to primary cilia via membrane microdomains and a targeting motif.  2570-2580. 2009

Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.  19:2011-2019. 2008

Oscillating cortical thick ascending limb cells at the juxtaglomerular apparatus.  19. 2008

Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis.  19:1681-1691. 2008

Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis.  19:1629-1633. 2008

Impact of activated vitamin D and race on survival among hemodialysis patients.  19:1379-1388. 2008

Systolic dysfunction portends increased mortality among those waiting for renal transplant.  19:1190-1196. 2008

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.  19:615. 2008

Antiproteinuric therapy and fabry nephropathy: Sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-β.  18:2609-2617. 2007

Advances in urinary proteome analysis and biomarker discovery.  18:1057-1071. 2007

Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study.  18. 2007

EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells.  18:131-142. 2007

Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.  17:1710-1715. 2006

IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease.  16:3651-3660. 2005

Towards a definition and classification of acute kidney injury.  16. 2005

Connective tissue growth factor (CTGF) N fragment: A marker for progressive diabetic nephropathy..  249A-249A. 2002

Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT1 receptors.  1131. 2002

Purinergic receptor signaling at the basolateral membrane of macula densa cells.  1145-1151. 2002

Renal response to tissue injury: Lessons from heme oxygenase-1 gene ablation and expression.  11. 2000

Glycolate metabolism by Hep G2 cells.  10. 1999

Temporal Induction of Clusterin in Cisplatin Nephrotoxicity 1997

Dominantly transmitted glomerulocystic kidney disease A distinct genetic entity.  77-84. 1997

Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation.  1930-1941. 1997

Homocysteine and folate concentrations in blood from patients treated with hemodialysis 1996

Gene expression of epithelial glucose transporters: the role of diabetes mellitus..  5:S29-S36. 1994

Effects of insulin and glucose on renal phosphate reabsorption: Interactions with dietary phosphate.  2:1593. 1992

Influence of adenosine receptor blockade on renal function and renal autoregulation.  2:991-999. 1991

Albuminuria and racial disparities in the risk for ESRD.  22:1721-1728.

Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery.  29:260-267.

An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria.  28:494.

Angiotensin II stimulates macula densa basolateral sodium/hydrogen exchange via type 1 angiotensin II receptors.  10.

Efficacy and safety of renal tubule cell therapy for acute renal failure.  19.

Enzyme replacement therapy and fabry kidney disease: Quo vadis?.  18.

Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994.  9:853-858.

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.  16:2205-2215.

Heme oxygenase-1 gene polymorphisms-toward precision medicine for AKI.  27.

Hepatocyte growth factor alters renal epithelial cell susceptibility to uropathogenic Escherichia coli.  12:2543-2553.

Klotho and phosphate are modulators of pathologic uremic cardiac remodeling

Low socioeconomic status associates with higher serum phosphate irrespective of race.  21:1953-1960.

Macula densa nitric oxide synthase 1b protects against salt-sensitive hypertension.  27.

Mechanisms of light chain injury along the tubular nephron.  23.

Novel paradigms of salt and hypertension.  28.

Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption.  24:456.

Role of primary cilia in the pathogenesis of polycystic kidney disease.  18:1381-1388.

SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function.  28:981-994.

The kidney in sarcoidosis.  1555.

TβRI independently activates Smad- and CD2AP-dependent pathways in podocytes